Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: percodan / codeine / atorvastatin / tramadol / readi-cat / flagyl attending: chief complaint: pancreatitis and pseudocyst major surgical or invasive procedure: : 1. ercp : 1. open pancreatic necrosectomy and peripancreatic abscess drainage. 2. open cholecystectomy with fluoroscopic intraoperative cholangiography. 3. an 18-french malecot gastrostomy tube. 4. feeding jejunostomy tube - 12-french whistle-tip. : 1. ptc placement : 1. ptc exchange : 1. ptc exchange and upsizing : 1. aborted thoracentesis of the right side. 2. right video-assisted thoracic surgery decortication of loculated right pleural effusion. history of present illness: 69year old male with complaint of 6 weeks of abdominal pain with multiple admissions to for pancreatitis. has experienced a 37 pound weight loss over this time. over this course, amylase has returned to following an initial amylase of 2640. the patient reports doing well when kept npo, but the recurrence of sharp abdominal pain with po intake. pain is described as diffusely epigastric, sharp, constant at a , made worse with po intake, relieved with narcotic pain meds, non-radiating. patient also reports moderate nausea relieved with zofran. past medical history: 1. htn 2. copd (pfts in : fev1 75% predicted, moderate restrictive disease, significant response to bronchodilatator) 3. "silent" mi years ago (negative stress test in ) 4. hypertriglyceridemia 5. legally blind secondary to degenerative visual condition 6. chronic back pain social history: married. retired carpenter. smoked 1 ppd x 45 years; quit in the . rare alcohol. no illicits. family history: father died in his 70s from an mi. mother lived to her 90s and died from unclear causes. physical exam: on admission: avss/afebrile. gen: in nad. heent: legally blind. sclerae anicteric. o-p clear. cv: rrr; s1s2+ chest: cta(b). abd: bsx4. obese, soft, nt, non-rigid. g-j tube in place. ext: 1+ ankle edema neuro: a+ox3. . at discharge: avss/afebrile gen: well appearing in nad. heent: sclerae anicteric. o-p clear. neck: supple. no . no jvd. lungs: posterior apical and basal chest tubes to . prior ct site at anterior apical with occlussive dressing. slightly decreased bs (r) base, otherwise cta. cor: rrr; nl s1/s2 w/o m/c/r. abd: (l)uq g-tube clamped. (l)lq j-tube clamped for transport. both patent/intact. (r) ptc drain capped. tube insertion sites c/d/i. abdominal incision well approximated, healing well ota. bsx4. soft/nt/nd. extrem: mild ankle edema w/o pitting. no cyanosis, pallor. neuro: a+ox3. legally blind. otherwise non-focal/grossly intact. skin: wwp. pertinent results: on admission: 09:38pm glucose-105 urea n-8 creat-0.5 sodium-134 potassium-3.5 chloride-98 total co2-26 anion gap-14 09:38pm alt(sgpt)-170* ast(sgot)-187* alk phos-363* amylase-37 tot bili-2.8* 09:38pm lipase-33 09:38pm calcium-8.9 phosphate-4.2 magnesium-1.6 09:38pm wbc-10.8 rbc-3.66* hgb-9.5* hct-29.5* mcv-81* mch-26.1* mchc-32.4 rdw-14.9 09:38pm plt count-398 . imaging: ct abd/pelvis: pancreatitis, pseudocysts, smv thrombosis cta pancr abd/pelvis: confirmed smv thrombosis on venous phase upper gi no oral contrast is seen beyond the duodenal bulb . cxr patchy consolidation of the rul, bigger r pleural effusion cxr: large r pleural effusion, additional loculated pleural fluid cxr: large focal consolidation in the right lower lobe with loculated pleural effusion and multiple chest tubes on the right, no appreciable change since prior study.small l pleural effusion cxr: dense opacification of the right hemithorax with three chest tubes on the right. the loculated right-sided pleural effusion appears to be somewhat less dense at the right periphery and there appears to be mildly improved opacification of the right lung. dense effusion at the right lung apex and at the right lung base. left lung is relatively clear cxr: right loculated pleural effusion is associated with small amount of air component, difficult to assess in this single frontal semi-upright view. this is unchanged from prior. right chest tubes remain in place. cardiomediastinal contour is unchanged. the left lung is grossly clear besides linear atelectasis in the base. cxr: substantial right pleural effusion, particularly basal, persist despite presence of three right pleural tubes, one at the apex, one along the mediastinum and one coiled at the right base. attendant atelectasis is persistent, most severe in the middle and lower lobes. left lung clear. heart size normal. no endotracheal tube is seen below c7, theupper margin of this film. cxr: the examination is compared to . the three right-sided chest tubes show an unchanged course and position. the extent of the lateral pleural opacities have minimally decreased, the extent of the more medial pleural opacities are without relevant change. there is no evidence of pneumothorax. unchanged blunting of the right costophrenic sinus suggesting a small pleural effusion. unchanged opacities along one of the three chest tubes. the left lung is unremarkable. am cxr: as compared to the previous radiograph, the position of the right-sided chest tube is unchanged. in the interval, a minimal decrease of the right pleural fluid has occurred. the transparency of the right-sided lung parenchyma is minimally improved. in the left lung, no relevant changes are seen. no evidence of interval recurrence of focal parenchymal opacity suggesting pneumonia. no left pleural effusion. pm cxr: p.... . microbiology: . 12:45 pm swab pancreatic abscess. **final report ** gram stain (final ): 1+ (<1 per 1000x field): polymorphonuclear leukocytes. 2+ (1-5 per 1000x field): gram negative rod(s). wound culture (final ): klebsiella pneumoniae. moderate growth. klebsiella pneumoniae. moderate growth. second morphology. sensitivities: mic expressed in mcg/ml _________________________________________________________ klebsiella pneumoniae | klebsiella pneumoniae | | ampicillin/sulbactam-- 4 s 8 s cefazolin------------- <=4 s <=4 s cefepime-------------- <=1 s <=1 s ceftazidime----------- <=1 s <=1 s ceftriaxone----------- <=1 s <=1 s cefuroxime------------ 2 s 16 i ciprofloxacin---------<=0.25 s <=0.25 s gentamicin------------ <=1 s <=1 s meropenem-------------<=0.25 s <=0.25 s piperacillin/tazo----- <=4 s 8 s tobramycin------------ <=1 s <=1 s trimethoprim/sulfa---- <=1 s <=1 s anaerobic culture (final ): bacteroides fragilis group. sparse growth. beta lactamase positive. . 9:29 pm tissue pleura right side. gram stain (final ): 2+ (1-5 per 1000x field): polymorphonuclear leukocytes. no microorganisms seen. tissue (preliminary): klebsiella pneumoniae. sparse growth. citrobacter freundii complex. sparse growth. sensitivities: mic expressed in mcg/ml _________________________________________________________ klebsiella pneumoniae | citrobacter freundii ampicillin/sulbactam-- 8 s cefazolin------------- <=4 s cefepime-------------- <=1 s <=1 s ceftazidime----------- <=1 s 2 s ceftriaxone----------- <=1 s <=1 s cefuroxime------------ 4 s ciprofloxacin---------<=0.25 s <=0.25 s gentamicin------------ <=1 s <=1 s meropenem-------------<=0.25 s <=0.25 s piperacillin---------- <=4 s piperacillin/tazo----- <=4 s tobramycin------------ <=1 s <=1 s trimethoprim/sulfa---- <=1 s <=1 s anaerobic culture (final ): no anaerobes isolated. 12:45 pm swab pancreatic abscess. gram stain (final ): 1+ (<1 per 1000x field): polymorphonuclear leukocytes. 2+ (1-5 per 1000x field): gram negative rod(s). wound culture (final ): klebsiella pneumoniae. moderate growth. klebsiella pneumoniae. moderate growth. second morphology. sensitivities: mic expressed in mcg/ml ______________________________________________________ klebsiella pneumoniae | klebsiella pneumoniae | | ampicillin/sulbactam-- 4 s 8 s cefazolin------------- <=4 s <=4 s cefepime-------------- <=1 s <=1 s ceftazidime----------- <=1 s <=1 s ceftriaxone----------- <=1 s <=1 s cefuroxime------------ 2 s 16 i ciprofloxacin---------<=0.25 s <=0.25 s gentamicin------------ <=1 s <=1 s meropenem-------------<=0.25 s <=0.25 s piperacillin/tazo----- <=4 s 8 s tobramycin------------ <=1 s <=1 s trimethoprim/sulfa---- <=1 s <=1 s anaerobic culture (final ): bacteroides fragilis group. sparse growth. beta lactamase positive. . mrsa screen (final ): no mrsa isolated. brief hospital course: the patient was admitted to the general surgical service for further evaluation of pancreatitis and a pseudocyst after undergoing a failed ercp. the ercp demonstrated severe edema of the distal stomach and bulb causing narrowing with a spontaneous drainage of pruluent material from the bulb, most likely due to a large pseudocyst or fluid collection. unable to pass the ercp scope beyond the bulb. he was made npo, an ng tube was placed, started on iv fluid, a foley catheter was placed, and he was started on iv unasyn. routine labwork, cxr, and ecg were performed. admission abdominal/pelvic ct demonstrated findings consistent with pancreatitis with note a pseudocyst. the study also showed mild intrahepatic biliary dilation, inflammation of the duodenum and cbd, as well as raised suspicion for smv thrombosis. a picc line was placed, and tpn was started. a cta pancreas protocol was perfomed on , which redemonstrated pancreatitis with numerous adjacent air and fluid filled pseudocysts, as well as a filling defect of the upper portion of the smv, consistent with smv thrombosis. there was no evidence of reactive pseudo-aneurysm formation. the patient was started on a heparin infusion, titrated until therapeutic. . on on , the patient underwent open pancreatic necrosectomy and peripancreatic abscess drainage, open cholecystectomy with fluoroscopic intraoperative cholangiography, and placement of both a gastrostomy and feeding jejunostomy tubes, which went well without complication (reader referred to the operative note for details). after a brief, uneventful stay in the pacu, the patient arrived on the floor npo with an ng tube, on iv fluids and antibiotics, with a foley catheter, j-tube and g-tube to gravity, a jp drain in place, and a dilaudid pca for pain control. he was continued on iv unasyn. the patient was hemodynamically stable. on pod#1, he required multiple iv fluid boluses totalling 1.5 liter as well as metoprolol iv for tachycardia and low urine output with good response. he accidentally self-discontinued his ng tube the as well, but did not require replacement. otherwise, his initial post-operative course was unremarkable. heparin infusion was restarted post-operatively. he was started on trophic tubefeeds via the j-tube on pod#6, which were advanced to goal. tpn was continued until pod#7, then discontinued. he got out of bed with physical therapy. his recovery progressed as expected. . on , however, the patient experienced tachycardia, dyspnea, and brbpr. a hematocrit was 15.7 down from 28.6 four days prior. heparin was stopped. the patient was transferred to the sicu. he received a total of 5 units of prbcs, and was stabilized. gastroenterology was consulted, recommending holding heparin, transfuse, continue ppi, and holding off on colonoscopy as inpatient unless bleeding re-occurs. while in the sicu, the patient developed parotiditis, which resolved later on the floor with sucking on drops and . tubefeeds were restarted toward goal. . when hemodynamically stable, the patient was returned to the floor on . he experienced increased abdominal pain and distension, despite venting the g-tube. abdominal/pelvic ct revealed an overall stable appearance of the abdomen and pelvis with persistent small fluid collection tracking lateral to the duodenum/posterior to the pancreatic head and small probable hepatic subcapsular fluid collection. on , the patient underwent ptc drainage of the perihepatic fluid collection with drainage catheter placed to gravity. given history of gib on heparin infusion, it was determined to start subcutaneous heparin prophylaxis only. at this point, his recovery again progressed. foley catheter was discontinued. staples were removed with steri-strips placed. g-tube was clamped. tubefeeds continued via the j-tube at goal. the patient continued to work with physical therapy. on , the ptc was capped, but then later uncapped and g-tube vented for abdominal pain, nausea and dyspnea. tubefeeds were held overnight. by , he was able to tolerate a clamped g-tube, capped ptc, j-tube feeds, and sips. the picc was discontinued on and the tip sent for culture for a temperature spike. iv vancomycin was added to unasyn. picc tip culture was negative. . on , the patient underwent ir cholangiogram demonstrating a stricture of the distal common bile duct, but no signs of bile leak. the pigtail drain was replaced with a new drain of the same size for better bile drainage, as the patient did not tolerate upsizing of the drain at that time. the day after the procedure, he was restarted on tubefeeds, clear liquids, and the ptc was capped, which he tolerated. he was also started on iv reglan to improve his gi motility. on , he underwent ptc evaluation in ir, which demonstrated no evidence of ductal dilatation, again with long area of narrowing in the lower cbd likely related to mass effect from edema. the ptc this time was successfully upsized to a 10 french drain. tubefeedings and diet were restarted, and the ptc subsequently capped. iv vancomycin and unasyn were discontinued, and discharge planning underway. . on , the patient again experienced abdominal pain and nausea, as well as dyspnea and increased oxygen demand. cxr revealed a marked increase in the extent of the pre-existing right pleural effusion, with the effusion occupying about one-half of the right hemithorax. also, signs of fluid overload. chest ct demonstrated a large multiloculated right pleural effusion, compressive atelectasis and patchy ground-glass opacities. on , the patient initially underwent an unsuccessful thoracentesis attempt of the right side, followed by a successful right video-assisted thoracic surgery (vats) decortication of loculated right pleural effusion (see operative notes for full details). three chest tubes were placed; anterior apical, posterior apical, and basilar chest tubes to suction. the patient was subsequently admitted to the sicu. . sicu course: tranferred to sicu for increased wob. a-line placed. lasix x2 given with good diuresis. self-resolved v-tach approx. 5sec x2, asymptomatic. rate controlled. : restarted tubefeeds via j-tube, pca for pain with good effect, cxr for this afternoon. tachycardia responsive to extra doses of metoprolol. increased dosing to q4 hrs. antibiotic discontinued. ptc drain clamped. pvc's, repleting electrolytes. pleural effusion growing gpr per initial report; infectious disease consulted. most likely a contaminate. suggest flagyl to cover clostridium if he gets worse or spikes a temperature. : pleural effusions growing gnr (correction from gpr stated previously), started on ciprofloxacin. tachypneic overnight, abg 7.41/51/107, cxr stable. . on , the patient was transferred back to the inpatient floor. he was tolerating a full liquid diet po and tubefeeds at goal via the j-tube, the g-tube was clamped, ptc drain was capped, and he had three chest tubes in place 10 15cm suction, an anterior apical, posterior apical, and basal. he was voiding without assistance, and ambulating well with assistance due to legal blind status, and not weakness. he was continued on ciprofloxacin. also, he continued to receive lasix approximately every other day for gentle diuresis. on , the culture of the pleural tissue returned with pan-sensitive klebsiella pneumoniae and citrobacter freundii complex; flagyl was added to cipro for more comprehensive gram negative coverage. all three chest tubes were placed to water seal, which he tolerated. on , a cxr revealed a minimal decrease of the right pleural fluid with minimally improved transparency of the right-sided lung parenchyma. in the left lung, no relevant changes are seen. no evidence of interval recurrence of focal parenchymal opacity suggesting pneumonia. no left pleural effusion. the anterior apical chest tube was discontinued, and pneumostats were placed on the remaining chest tubes (posterior apical and basal). . the patient had experienced some mild, non-specific pruritus starting , which developed into a rash and hand angioedema early overnight into . flagyl, intitiated on , was suspected and stopped. the patient was given benadryl, fexofenadine, and singulair with symptomatic improvement. otherwise, he remained stable. he will continue on fexofenadine and singulair for one week to prevent recurrent delayed hypersensitivity reaction. . at the time of discharge on , the patient was doing well, afebrile with stable vital signs. the patient was tolerating a regular diet, albeit not with completely adequate intake, and tubefeeds at goal via the j-tube, g-tube was clamped, ptc was capped, and posterior apical and basal chest tubes had pneumostats in place. he was ambulating with assistance due to visual impairment, voiding without assistance, moving his bowels, and pain was well controlled. infectious disease has recommended that he continue on ciprofloxacin for at least 3 weeks, preferably for 2 weeks after all his drains have been removed. he was discharged home with vna services. the patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. medications on admission: atenolol 50mg po daily. prilosec 20mg po daily. asa 81mg po daily. fenofibrate 200mg po daily. spiriva 18mcg 1 tab via inhalation daily. mvi 1 tab po daily. glucosamine calcium+d fish oil discharge medications: 1. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation: over-the-counter. 2. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po daily (daily). 3. atenolol 50 mg tablet sig: one (1) tablet po daily (daily). 4. hydromorphone 2 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*70 tablet(s)* refills:*0* 5. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 6. tiotropium bromide 18 mcg capsule, w/inhalation device sig: one (1) cap inhalation daily (daily). 7. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed for constipation. disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 8. camphor-menthol 0.5-0.5 % lotion sig: one (1) appl topical tid (3 times a day) as needed for itching, redness. disp:*1 large bottle* refills:*2* 9. fenofibrate micronized 200 mg capsule sig: one (1) capsule po once a day. 10. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po once a day. disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 11. calcium 500 with vitamin d oral 12. fish oil oral 13. ciprofloxacin 500 mg tablet sig: one (1) tablet po q12h (every 12 hours) for 17 days. disp:*34 tablet(s)* refills:*0* 14. montelukast 10 mg tablet sig: one (1) tablet po daily (daily). disp:*7 tablet(s)* refills:*0* 15. fexofenadine 60 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for pruritus for 7 days. disp:*14 tablet(s)* refills:*0* 16. benadryl 25 mg capsule sig: one (1) capsule po every six (6) hours as needed for itching. disp:*30 capsule(s)* refills:*0* 17. lasix 20 mg tablet sig: one (1) tablet po every other day for 10 days. disp:*5 tablet(s)* refills:*0* 18. nebulizer & compressor for neb device sig: one (1) device miscellaneous as directed. disp:*1 unit* refills:*0* 19. nebulizer accessories kit sig: one (1) kit with hand-held nebulizer and tubing miscellaneous as directed. disp:*1 unit* refills:*2* 20. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: one (1) neb inhalation four times a day as needed for shortness of breath or wheezing. disp:*25 pre-filled nebs* refills:*4* discharge disposition: home with service facility: homecare discharge diagnosis: 1. complicated gallstone pancreatitis. 2. smv thrombosis 3. moderate intrahepatic ductal dilatation and severe common bile duct dilatation 4. loculated right pleural effusion. discharge condition: good discharge instructions: please call your doctor or nurse practitioner or return to the emergency department for any of the following: *you experience new chest pain, pressure, squeezing or tightness. *new or worsening cough, shortness of breath, or wheeze. *if you are vomiting and cannot keep down fluids or your medications. *you are getting dehydrated due to continued vomiting, diarrhea, or other reasons. signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *you see blood or dark/black material when you vomit or have a bowel movement. *you experience burning when you urinate, have blood in your urine, or experience a discharge. *your pain is not improving within 8-12 hours or is not gone within 24 hours. call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *you have shaking chills, or fever greater than 101.5 degrees fahrenheit or 38 degrees celsius. *any change in your symptoms, or any new symptoms that concern you. please resume all regular home medications , unless specifically advised not to take a particular medication. also, please take any new medications as prescribed. please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. avoid lifting weights greater than lbs until you follow-up with your surgeon. avoid driving or operating heavy machinery while taking pain medications. incision care: *please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *avoid swimming and baths until your follow-up appointment. *you may shower, and wash surgical incisions with a mild soap and warm water. gently pat the area dry. *if you have staples, they will be removed at your follow-up appointment. *if you have steri-strips, they will fall off on their own. please remove any remaining strips 7-10 days after surgery. . general drain care: . *please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). *if the drain is connected to a collection container, please note color, consistency, and amount of fluid in the drain. call the doctor, nurse practitioner, or vna nurse if the amount increases significantly or changes in character. be sure to empty the drain frequently. record the output, if instructed to do so. *wash the area gently with warm, soapy water, pat dry, and place a drain sponge if needed daily and prn. *keep the insertion site clean and dry otherwise. *avoid swimming, baths, hot tubs; do not submerge yourself in water. *make sure to keep the drain attached securely to your body to prevent pulling or dislocation. . chest tube with information you are ready to go home, but still need your chest tube. a small device, called an atrium , has been placed on the end of your chest tube to help you get better. about the atrium : the atrium is made to allow air and a little fluid to escape from your chest until your lung heals. the device will hold 30ml of fluid. empty the device as often as needed (see directions below) and keep track of how much you empty each day. items needed for home use: ?????? atrium chest drain valve (provided by hospital) ?????? -lock syringes to empty drainage, if needed (provided by hospital or vna nurse) ?????? wound dressings (provided by hospital or vna nurse) securing the : utilize the pre-attached garment clip to secure the to your clothes. it is small and light enough that you won't even feel it hanging at your side. make sure to keep the in an upright position as much as possible. before lying down to sleep or rest, empty the so there will be no fluid to potentially leak out. wound dressing: you have a dressing around your chest tube. this should be changed at least every other day or as prescribed by your doctor. showering/bathing: showering with a chest tube is all right as long as you don't submerge the tube or device in water. no baths, swimming, or hot tubs. note: this device is very important and the tubing must stay attached to the end of your chest tube. ?????? if it falls off, reconnect it immediately and tape it securely. ?????? if it falls off and you can't get it back together, go to the closest hospital emergency room. warnings: 1. do not obstruct the air leak well. 2. do not clamp the patient tube during use. 3. do not use or puncture the needleless port with a needle. 4. do not leave a syringe attached to the needleless port. 5. do not connect -lock connector to the needleless port located on the bottom of the chest drain valve. 6. if at any time you have concerns or questions, contact your nurse . the ?????? keep the in an upright position and make sure the tubing stays firmly attached to the end of your chest tube. make sure the stays clean and dry. do not allow the to completely fill with fluid or it may start to leak out. if fluid does leak out, clean off the and use a q-tip to dry out the valve. ?????? if the becomes full with fluid, empty it using a -lock syringe. firmly screw the -lock onto the port located on the bottom of the . ?????? pull the plunger back on the syringe to empty the fluid. when the syringe is full, unscrew the syringe and empty the fluid into the nearest suitable receptacle. repeat as necessary. if it becomes difficult to empty the fluid using a syringe, squirt water through the port to flush out the blockage or consult your nurse . may need to be changed out. . right abdominal ptc drain is capped. if you experiences fever, uncap the ptc and place to collection bag. call interventional radiology fellow for further instructions. weekdays: ( . nights/weekends: interventional radiology fellow/resident - call page operator ( and ask for pager# . call the vna nurse or dr. office if unsure with carrying out the above procedure, or proceed to the emergency room. followup instructions: please call ( to arrange a follow-up appointment with dr. (pcp) in 2 weeks. . provider: , md (surgery). phone: (. date/time: at 9:45am. location: 3, . . provider: , md phone: date/time: 9:00. location: chest disease center, bldg., i . the patient will be contact by interventional radiology to arrange post-discharge follow-up. procedure: parenteral infusion of concentrated nutritional substances other enterostomy other endoscopy of small intestine enteral infusion of concentrated nutritional substances thoracentesis drainage of pancreatic cyst by catheter cholecystectomy intraoperative cholangiogram other gastrostomy other cholangiogram other percutaneous procedures on biliary tract other excision or destruction of lesion or tissue of pancreas or pancreatic duct replacement of stent (tube) in biliary or pancreatic duct replacement of stent (tube) in biliary or pancreatic duct thoracoscopic decortication of lung diagnoses: unspecified essential hypertension friedl?nder's bacillus infection in conditions classified elsewhere and of unspecified site acute posthemorrhagic anemia hyposmolality and/or hyponatremia chronic airway obstruction, not elsewhere classified cardiac complications, not elsewhere classified hematoma complicating a procedure personal history of tobacco use pleurisy with effusion, with mention of a bacterial cause other than tuberculosis pure hyperglyceridemia paroxysmal ventricular tachycardia acute respiratory failure peritoneal adhesions (postoperative) (postinfection) other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation angioneurotic edema, not elsewhere classified anticoagulants causing adverse effects in therapeutic use other specified disorders of stomach and duodenum acute vascular insufficiency of intestine spinal stenosis, unspecified region obstruction of bile duct diverticulosis of colon with hemorrhage acute pancreatitis cyst and pseudocyst of pancreas legal blindness, as defined in u.s.a. other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms sialoadenitis other antiprotozoal drugs causing adverse effects in therapeutic use calculus of gallbladder and bile duct with other cholecystitis, without mention of obstruction 

Answer: The patient is high likely exposed to